Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
When Context Changes an Apoptosis Result
2026-11-19
An Annexin V signal is a measurement of cell-surface phosphatidylserine exposure, not an isolated diagnosis of apoptosis. In postinfarction research, its meaning depends on how the assay is connected to macrophage metabolism, cardiomyocyte injury, tissue remodeling, and functional outcomes.
Annexin V-PE Apoptosis Kit and Cardiac Repair
2026-11-18
Annexin V fluorescence can contextualize apoptosis-associated phosphatidylserine exposure in cardiac-injury research, but it does not independently establish cell death, mechanism, or therapeutic benefit. The ENO1 study supports a macrophage metabolism–lactate–KLF4 model while leaving the assay-specific and translational conclusions appropriately bounded.
Annexin V Readouts in Postinfarction Repair
2026-11-18
Annexin V fluorescence provides a downstream measure of cell-surface phosphatidylserine exposure in the ENO1–lactate–KLF4 model of postinfarction inflammation. The readout helps contextualize cardiomyocyte apoptosis, but it does not independently establish the upstream mechanism, irreversible cell death, or therapeutic efficacy.
SIRT1 and Vascular–Osteogenic Aging
2026-11-17
A multilevel preclinical study links age-associated SIRT1 decline with deterioration of type H vasculature, osteogenic activity, and skeletal regeneration, while identifying β-catenin/Wnt signaling and soluble endothelial–stromal communication as candidate mediators.
ENO1 Metabolism and Cardiac Repair After MI
2026-11-17
A preclinical study examines whether ENO1 links glycolytic remodeling to inflammatory macrophage behavior after myocardial infarction and whether an acid-responsive nanocarrier can test that mechanism through targeted siRNA delivery. The reported findings connect ENO1 silencing with altered macrophage metabolism, inflammatory-marker suppression, and improved cardiac-tissue measurements in mice, while leaving important questions about translation, long-term safety, and molecular directness.
Annexin V Signals in Postinfarction Cardiac Repair
2026-11-16
A source-grounded interpretation of annexin V apoptosis measurements within a preclinical study of ENO1, macrophage metabolism, and postinfarction repair. The evidence supports a coherent mechanistic model, while leaving assay specificity, intervention attribution, and translation unresolved.
ENO1, Macrophage Metabolism, and Cardiac Repair
2026-11-16
A 2026 study linked ENO1-driven glycolytic remodeling in postinfarction macrophages to lactate accumulation, KLF4 suppression, inflammation, and impaired cardiac repair. Its Annexin V-based apoptosis readout was one downstream measurement within a broader evidence chain rather than independent proof of the upstream mechanism.
ENO1, Macrophage Metabolism and Cardiac Repair
2026-11-15
A paper-centred interpretation of a preclinical study linking ENO1-driven glycolytic remodeling in infarct-associated macrophages with inflammatory polarization and cardiac repair. The work combines transcriptomics, metabolic perturbation, an acid-responsive siRNA nanocarrier, and murine myocardial-infarction assessments, while leaving important questions about mechanism, durability, and translation unresolved.
ENO1, Macrophage Metabolism and Cardiac Repair
2026-11-14
A paper-centred interpretation of a preclinical study linking ENO1-driven metabolic remodeling in postinfarction macrophages to inflammatory polarization, and evaluating an acid-responsive nanocarrier for targeted siRNA delivery in murine models.
ENO1, Macrophage Metabolism, and Cardiac Repair
2026-11-13
A preclinical study links ENO1-driven metabolic remodeling in infarct-associated macrophages with inflammatory polarization and evaluates an acid-responsive nanocarrier for localized siRNA delivery. The findings support a macrophage-centered mechanism for post-infarction repair while remaining limited to experimental models.
ENO1, Macrophage Metabolism, and Cardiac Repair
2026-11-13
A preclinical study examines ENO1 as a metabolic regulator of inflammatory macrophages after myocardial infarction and tests an acid-responsive nanocarrier for localized siRNA delivery. The findings connect ENO1 silencing with reduced glycolytic activity, altered lactate–KLF4 signaling, macrophage-state changes, and improved structural and functional cardiac readouts in mice.
SIRT1 Links Bone Vessels and Osteogenesis
2026-11-12
A preclinical study links age-associated SIRT1 decline with impaired type H vasculature, osteogenic activity, and endothelial–mesenchymal coordination in bone. Across aged mice and senescent cell models, SIRT1 modulation affected vascular and osteogenic phenotypes, with β-catenin signaling emerging as a candidate molecular intermediary.
Annexin V Readouts in ENO1 Cardiac Repair
2026-11-12
Annexin V fluorescence occupies the downstream measurement layer of the reported ENO1 cardiac-repair study. It can indicate cell-surface phosphatidylserine exposure associated with dying cells, but it does not independently establish apoptosis, the ENO1–lactate–KLF4 mechanism, or therapeutic efficacy.
ENO1, Macrophage Metabolism, and Cardiac Repair
2026-11-11
Li et al. identify ENO1 as a metabolic regulator of inflammatory macrophage behavior after myocardial infarction and connect its silencing to reduced lactate, recovery of KLF4-associated reparative programs, and improved cardiac remodeling in preclinical models. This editorial separates the mechanistic evidence from the Annexin V-based apoptosis-associated readout and defines the study’s translational limits.
ENO1, Macrophage Metabolism and Cardiac Repair
2026-11-11
A preclinical study examines whether ENO1 links post-infarction macrophage metabolism to inflammatory polarization and cardiac repair. It also evaluates an acid-responsive nanocarrier designed to deliver ENO1-targeting siRNA preferentially to infarct-associated macrophages.